Quick Takeaways
- Verve Capital Ltd filed SCHEDULE 13G/A for VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share (VOR).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
Verve Capital Ltd - 31 Dec 2025 SCHEDULE 13G/A Report for VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share (VOR)
- Filing Manager
- Verve Capital Ltd
- Reporting Manager
- Verve Capital Limited
- Symbol
- VOR
- Shares outstanding
- 43,408,727 shares
- Disclosed Ownership
- 4,297,464 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 18:59:30 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 26 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Verve Capital Ltd disclosed 9.9% ownership in VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share (VOR) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 26 Sep 2025.
- Current filing was accepted on 17 Feb 2026, 18:59.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Verve Capital Limited | 9.9% | 4,297,464 | 4,297,464 | 0 | /s/ Hongtu Zhu | By Hongtu Zhu, Director |